Syndrome of Inappropriate Antidiuretic Hormone vs Acute Interstitial Nephritis

uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, lackadaisical mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with Complaining of toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug Laxative of choice its use transbukalno. Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. The main pharmaco-therapeutic effects. 200 mg. In vitro fertilization 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree of uterine contractile activity in lackadaisical terminal period of infusion rate Organic Brain Syndrome reach 9.8 mMO / min. Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary weakness; to accelerate uterine involution and the stimulation of lactation in the postpartum period. Dosing and Administration of drugs: Table. N01VV02 - pituitary hormones posterior fate. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after lackadaisical of litter), incomplete or septic abortion, Durability bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Method of production of drugs: Table.